Skip to main content
Clover Biopharmaceuticals, Ltd. logo

Clover Biopharmaceuticals, Ltd. — Investor Relations & Filings

Listed
Ticker · 2197 ISIN · KYG2280A1076 HKEX Manufacturing
Open in API
Filings indexed 221 across all filing types
Latest filing 2026-06-18 Governance Information
Country HK Hong Kong
Listing HKEX 2197 · 1 venue

About Clover Biopharmaceuticals, Ltd.

http://www.cloverbiopharma.com

Clover Biopharmaceuticals, Ltd. is a global commercial-stage biotechnology company specializing in the research, development, manufacturing, and commercialization of innovative vaccines and biotherapeutic candidates. The company's core mission is to improve global health outcomes by addressing significant unmet medical needs, including infectious diseases, cancer, and autoimmune conditions. Clover utilizes its proprietary Trimer-Tag technology platform, which facilitates the development of stabilized trimeric protein antigens and biologics. Supported by in-house manufacturing and commercial infrastructure, Clover focuses on delivering its innovative pipeline products to populations worldwide.

Recent filings

Filing Released Lang Actions
SIXTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
Governance Information Classification · 95% confidence The document is a detailed legal and corporate governance text titled "Sixth Amended and Restated Memorandum and Articles of Association of Clover Biopharmaceuticals, Ltd." It includes sections on company formation, share capital, meetings, voting rights, and board structure, adopted by special resolution. Such documents are fundamental governance charters defining internal rules, board structure, member rights, and corporate procedures. It does not present financial performance data, audit results, earnings, or market presentations. Rather, it establishes governance framework and internal company regulations under the Companies Act of the Cayman Islands. Therefore, this document best fits within Governance Information (CGR).
2026-06-18 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 18, 2026
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is titled "POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 18, 2026" which clearly indicates it is an announcement of voting outcomes at an AGM. The text describes the poll results for various resolutions including adoption of financial statements, re-election of directors, mandate for shares issuances and repurchases, amendment of the memorandum and articles of association, and auditor reappointment. There is no detailed financial data or the full annual report financial statements included; rather, it is a formal announcement of voting results related to the AGM resolutions. This matches the definition of "Declaration of Voting Results & Voting Rights Announcements (DVA)" which are official results from shareholder votes at general meetings. The length of the document (7430 characters) supports it containing full voting results details rather than a brief note. Hence, the document is best classified as DVA with high confidence.
2026-06-18 English
SUPPLEMENTAL ANNOUNCEMENT
Regulatory Filings Classification · 78% confidence The document is an HKEx "Supplemental Announcement" updating disclosures in the previously released Annual Results Announcement and Annual Report, providing additional compliance details. It does not contain actual financial statements or constitute the full annual report; instead, it is a stand-alone regulatory update. It is not a director trading report, earnings release, or governance charter. Under the classification rules, this type of exchange announcement falls under the generic Regulatory Filings category (RNS).
2026-06-05 English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended May 31, 2026
Share Issue/Capital Change Classification · 85% confidence The document is a mandatory monthly return filed with HKEX under Chapter 19B of the Listing Rules, detailing movements in authorized share capital, issued shares, treasury shares, share options and public float confirmations. It is not an earnings release, annual report, audit report or mere publication announcement, but rather an announcement of share capital movements and issuances. This fits the “Share Issue/Capital Change” category.
2026-06-03 English
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 93% confidence The document is a Form of Proxy for an Annual General Meeting, providing shareholders with instructions to appoint proxies and vote on resolutions. This is a classic proxy solicitation material sent to shareholders to request votes for a corporate meeting, fitting the Proxy Solicitation & Information Statement category.
2026-05-26 English
(1). PROPOSED GRANT OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES AND/OR SELL OR TRANSFER TREASURY SHARES; (2). PROPOSED RE-ELECTION OF THE RETIRING DIRECTORS; (3). PROPOSED RE-APPO
Proxy Solicitation & Information Statement Classification · 92% confidence The document is a shareholder circular providing detailed information on resolutions to be proposed at the Annual General Meeting, including mandates to repurchase and issue shares, re-election of directors, auditor appointment, amendments to the articles, and contains the formal notice of the AGM along with proxy instructions. It is clearly a proxy solicitation and information statement distributed to shareholders ahead of the meeting. Therefore, it matches the “Proxy Solicitation & Information Statement” category.
2026-05-26 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.